Summary of MMP13
This gene encodes for proteins that are involved in the breakdown of the extracellular matrix in normal bodily processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and malignant cell growth [R]
The Function of MMP13
Plays a role in the degradation of extracellular matrix proteins including fibrillar collagen, fibronectin, TNC and ACAN. Cleaves triple helical collagens, including type I, type II and type III collagen, but has the highest activity with soluble type II collagen. Can also degrade collagen type IV, type XIV and type X. May also function by activating or degrading key regulatory proteins, such as TGFB1 and CTGF. Plays a role in wound healing, tissue remodeling, cartilage degradation, bone development, bone mineralization and ossification. Required for normal embryonic bone development and ossification. Plays a role in the healing of bone fractures via endochondral ossification. Plays a role in wound healing, probably by a mechanism that involves proteolytic activation of TGFB1 and degradation of CTGF. Plays a role in keratinocyte migration during wound healing. May play a role in cell migration and in tumor cell invasion.
Protein names
Recommended name:
Collagenase 3Short name:
MMP-13Alternative name(s):
Matrix metalloproteinase-13- RS2252070 (MMP13) ??
- RS74380195 (MMP13) ??
To see your genotype, you should be logged in and have a file with your genotype uploaded.
Top Gene-Substance Interactions
MMP13 Interacts with These Diseases
Disease | Score |
Substances That Increase MMP13
Substances | Interaction | Organism | Category |
Substances That Decrease MMP13
Substances | Interaction | Organism | Category |
Advanced Summary
From NCBI Gene: Spondyloepimetaphyseal dysplasia, Missouri typeMetaphyseal chondrodysplasia, Spahr typeFrom UniProt: Metaphyseal anadysplasia 1 (MANDP1): A bone development disorder characterized by skeletal anomalies that resolve spontaneously with age. Clinical characteristics are evident from the first months of life and include slight shortness of stature and a mild varus deformity of the legs. Patients attain a normal stature in adolescence and show improvement or complete resolution of varus deformity of the legs and rhizomelic micromelia. [MIM:602111] Metaphyseal dysplasia, Spahr type (MDST): An autosomal recessive, rare disease characterized by moderate short stature, mild genua vara, and radiographic signs of metaphyseal dysplasia, but no biochemical signs of rickets. [MIM:250400] Spondyloepimetaphyseal dysplasia Missouri type (SEMD-MO): A bone disease characterized by moderate to severe metaphyseal changes, mild epiphyseal involvement, rhizomelic shortening of the lower limbs with bowing of the femora and/or tibiae, coxa vara, genu varum and pear-shaped vertebrae in childhood. Epimetaphyseal changes improve with age. [MIM:602111]
From NCBI Gene: This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This protease cleaves type II collagen more efficiently than types I and III. It may be involved in articular cartilage turnover and cartilage pathophysiology associated with osteoarthritis. Mutations in this gene are associated with metaphyseal anadysplasia. This gene is part of a cluster of MMP genes on chromosome 11. [provided by RefSeq, Jan 2016] From UniProt: Plays a role in the degradation of extracellular matrix proteins including fibrillar collagen, fibronectin, TNC and ACAN. Cleaves triple helical collagens, including type I, type II and type III collagen, but has the highest activity with soluble type II collagen. Can also degrade collagen type IV, type XIV and type X. May also function by activating or degrading key regulatory proteins, such as TGFB1 and CTGF. Plays a role in wound healing, tissue remodeling, cartilage degradation, bone development, bone mineralization and ossification. Required for normal embryonic bone development and ossification. Plays a role in the healing of bone fractures via endochondral ossification. Plays a role in wound healing, probably by a mechanism that involves proteolytic activation of TGFB1 and degradation of CTGF. Plays a role in keratinocyte migration during wound healing. May play a role in cell migration and in tumor cell invasion.
Conditions with Increased Gene Activity
Condition | Change (log2fold) | Comparison | Species | Experimental variables | Experiment name |
---|
Conditions with Decreased Gene Activity
Condition | Change (log2fold) | Comparison | Species | Experimental variables | Experiment name |
---|
Technical
The following transcription factors affect gene expression:
Tissue specificity:
Detected in fetal cartilage and calvaria, in chondrocytes of hypertrophic cartilage in vertebrae and in the dorsal end of ribs undergoing ossification, as well as in osteoblasts and periosteal cells below the inner periosteal region of ossified ribs. Detected in chondrocytes from in joint cartilage that have been treated with TNF and IL1B, but not in untreated chondrocytes. Detected in T lymphocytes. Detected in breast carcinoma tissue.
Gene Pathways:
Induction:
Up-regulated by TNF and IL1B.
Enzyme Regulation:
Inhibited by TIMP1, TIMP2 and TIMP3. Inhibited by acetohydroxamic acid and other zinc chelators.
Cofactor:
Binds 2 Zn(2+) ions per subunit.
Molecular Function:
- Calcium Ion Binding
- Collagen Binding
- Metalloendopeptidase Activity
- Serine-Type Endopeptidase Activity
- Zinc Ion Binding
Biological Processes:
- Bone Mineralization
- Bone Morphogenesis
- Cellular Protein Metabolic Process
- Collagen Catabolic Process
- Endochondral Ossification
- Extracellular Matrix Disassembly
- Growth Plate Cartilage Development
- Proteolysis
- Cellular Response To Fluid Shear Stress
- Embryonic Hindlimb Morphogenesis
- Estrous Cycle
- Heart Development
- Luteolysis
- Osteoblast Differentiation
- Parturition
- Peptide Catabolic Process
- Positive Regulation Of Pancreatic Trypsinogen Secretion
- Response To Estrogen
- Response To Hypoxia
- Response To Mechanical Stimulus